Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

DBVT

DBV Technologies S.A.

CIK 0001613780 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$16.08
↓ 0.67 (-4.00%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Technicals; Excluded: Options (no data)

Key stats

Market Cap
$4.76B
P/E Ratio
-28.43
EPS
-1.05
Dividend Yield
Not covered
52W Position
43%
Beta
0.97

Valuation multiples

Fwd P/E
Not covered
PEG
0.00
P/B
22.90
P/S
823.16
EV/Revenue
783.53
ROE
-80.6%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 43%
$8.51$26.18

Latest Financials

2025-12-31 FY
Revenue
$5.64M
Net Income
-$146.95M
Total Assets
$233.72M
Free Cash Flow
-$121.71M

Recent news